: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Tuberculosis

Free Subscription

Articles published in Int J Tuberc Lung Dis
Retrieve available abstracts of 410 articles:
HTML format

Single Articles

June 2022

LAZARCHIK A, Nyaruhirira AU, Chiang CY, Wares F, et al
Global availability of susceptibility testing for second-line anti-tuberculosis agents.
Int J Tuberc Lung Dis. 2022;26:524-528.
PubMed Abstract available

PELZER PT, Smit Y, Tiemersma EW, Huong NT, et al
Does BCG vaccination protect against infection with M. tuberculosis?
Int J Tuberc Lung Dis. 2022;26:529-536.
PubMed Abstract available

SINHA P, Bhargava A, Carwile M, Cintron C, et al
Undernutrition can no longer be an afterthought for global efforts to eliminate TB.
Int J Tuberc Lung Dis. 2022;26:477-480.
PubMed

BOEKELHEIDE K, Olugbosi M, Nedelman J, Everitt D, et al
Male reproductive hormones in patients treated with pretomanid.
Int J Tuberc Lung Dis. 2022;26:558-565.
PubMed Abstract available

KANIGA K, Lounis N, Zhuo S, Bakare N, et al
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline.
Int J Tuberc Lung Dis. 2022;26:571-573.
PubMed

LAURSEN LL, Dahl VN, Wejse C
Stool testing for pulmonary TB diagnosis in adults.
Int J Tuberc Lung Dis. 2022;26:516-523.
PubMed Abstract available

SHIN AY, Jekarl DW, Kim HW, Ha JH, et al
Early line-probe assay using DNA specimens in patients with pulmonary TB.
Int J Tuberc Lung Dis. 2022;26:509-515.
PubMed Abstract available

NAUFAL F, Chaisson LH, Robsky KO, Delgado-Barroso P, et al
Number needed to screen for TB in clinical, structural or occupational risk groups.
Int J Tuberc Lung Dis. 2022;26:500-508.
PubMed Abstract available

MALIK AA, Amanullah F
Source case investigation can reduce the diagnostic gap for childhood TB.
Int J Tuberc Lung Dis. 2022;26:566-567.
PubMed

May 2022

GRANOZZI B, Bisognin F, Lombardi G, Dal Monte P, et al
TB mortality in low-incidence countries: can we reduce it further?
Int J Tuberc Lung Dis. 2022;26:467-469.
PubMed

GROSCHEL MI, van den Boom M, Dixit A, Skrahina A, et al
Management of childhood MDR-TB in Europe and Central Asia: report of a Regional WHO meeting.
Int J Tuberc Lung Dis. 2022;26:433-440.
PubMed Abstract available

SHAMPUTA IC, Nguyen DTK, Burdo T, Dao G, et al
Canadian immigrants awareness and perceptions of TB infection and TB.
Int J Tuberc Lung Dis. 2022;26:454-456.
PubMed

COOREY NJ, Kensitt L, Davies J, Keller E, et al
Risk factors for TB in Australia and their association with delayed treatment completion.
Int J Tuberc Lung Dis. 2022;26:399-405.
PubMed Abstract available

KRITSKI AL, Viveiros M, Carvalho ACC
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs.
Int J Tuberc Lung Dis. 2022;26:385-387.
PubMed

GANDHI R, Deepak KG, Verma G, Chaubey S, et al
Engaging private pharmacies to help end TB in India.
Int J Tuberc Lung Dis. 2022;26:457-459.
PubMed

NINAN MM, Rupali P, Varghese GM, Shalini EB, et al
Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls.
Int J Tuberc Lung Dis. 2022;26:441-445.
PubMed Abstract available

MALIK AA, Hussain H
Preventive treatment for MDR-TB exposure in households.
Int J Tuberc Lung Dis. 2022;26:466-467.
PubMed

CAPEDING TPJ, Rosa JD, Lam H, Gaviola DG, et al
Cost of TB prevention and treatment in the Philippines in 2017.
Int J Tuberc Lung Dis. 2022;26:392-398.
PubMed Abstract available

PALANI N, Premkumar M, Vaishnavee V, Dinesh V, et al
Trends in rifampicin and isoniazid resistance in patients with presumptive TB.
Int J Tuberc Lung Dis. 2022;26:446-453.
PubMed Abstract available

April 2022

MARCHESE V, Formenti B, Marchese L, Gregori N, et al
COVID-19 effect on TB presentation and outcome.
Int J Tuberc Lung Dis. 2022;26:375-377.
PubMed

KIM JW, Vella C, Parvez W, Verma R, et al
Impact of COVID-19 on the diagnosis and management of lung cancer and TB.
Int J Tuberc Lung Dis. 2022;26:372-374.
PubMed

ALLORANT A, Biswas S, Ahmed S, Wiens KE, et al
Finding gaps in routine TB surveillance activities in Bangladesh.
Int J Tuberc Lung Dis. 2022;26:356-362.
PubMed Abstract available

SHIVAKUMAR SVBY, Padmapriyadarsini C, Chavan A, Paradkar M, et al
Concomitant pulmonary disease is common among patients with extrapulmonary TB.
Int J Tuberc Lung Dis. 2022;26:341-347.
PubMed Abstract available

HUGHES G, Bern H, Chiang CY, Goodall RL, et al
QT prolongation in the STREAM Stage 1 Trial.
Int J Tuberc Lung Dis. 2022;26:334-340.
PubMed Abstract available

DEN BOON S, Lienhardt C, Zignol M, Schwartzman K, et al
WHO target product profiles for TB preventive treatment.
Int J Tuberc Lung Dis. 2022;26:302-309.
PubMed Abstract available

ADAMASHVILI N, Baliashvili D, Kuchukhidze G, Salindri AD, et al
Low BMI increases all-cause mortality rates in patients with drug-resistant TB.
Int J Tuberc Lung Dis. 2022;26:326-333.
PubMed Abstract available

PRADHAN NN, Paradkar MS, Kagal A, Valvi C, et al
Performance of Xpert((R)) MTB/RIF and Xpert((R)) Ultra for the diagnosis of tuberculous meningitis in children.
Int J Tuberc Lung Dis. 2022;26:317-325.
PubMed Abstract available

DOWDY DW, Islam MA
Finding TB s "missing millions", one district at a time.
Int J Tuberc Lung Dis. 2022;26:295.
PubMed

March 2022

SUMNER T, Jensen HT, Keogh-Brown MR, Vassall A, et al
Time to integrate epidemiological and economic models for TB.
Int J Tuberc Lung Dis. 2022;26:282-284.
PubMed

MBELELE PM, Sabiiti W, Heysell SK, Sauli E, et al
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease.
Int J Tuberc Lung Dis. 2022;26:276-278.
PubMed

MUSONDA HK, Rose PC, Switala J, Schaaf HS, et al
Paediatric admissions to a TB hospital: reasons for admission, clinical profile and outcomes.
Int J Tuberc Lung Dis. 2022;26:217-223.
PubMed Abstract available

MIGLIORI GB, Wu SJ, Matteelli A, Zenner D, et al
Clinical standards for the diagnosis, treatment and prevention of TB infection.
Int J Tuberc Lung Dis. 2022;26:190-205.
PubMed Abstract available

February 2022

TINOCO EM, Vasconcelos A, Alves F, Duarte R, et al
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services.
Int J Tuberc Lung Dis. 2022;26:178-180.
PubMed

ORTIZ-MARTINEZ Y, Rodriguez-Morales AJ, Henao-Martinez AF
Decreased notification of TB cases during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2022;26:177-178.
PubMed

SCHIZA V, Kruse M, Xiao Y, Kar S, et al
Impact of the COVID-19 pandemic on TB infection testing.
Int J Tuberc Lung Dis. 2022;26:174-176.
PubMed

GUREVA T, Turkova A, Yablokova E, Smirnova P, et al
Fluoroquinolone preventive therapy for children exposed to MDR-TB.
Int J Tuberc Lung Dis. 2022;26:171-173.
PubMed

BOHLBRO AS, Patsche CB, Mendes AM, Sifna A, et al
A self-rated health score predicts severe disease and high mortality in patients with pulmonary TB.
Int J Tuberc Lung Dis. 2022;26:158-165.
PubMed Abstract available

MOHR-HOLLAND E, Daniels J, Reuter A, Rodriguez CA, et al
Early mortality during rifampicin-resistant TB treatment.
Int J Tuberc Lung Dis. 2022;26:150-157.
PubMed Abstract available

BEAUMONT AL, Doumbia A, Chateau N, Meynard JL, et al
Why are people still dying of drug-susceptible TB in Paris in the 21(st) century?
Int J Tuberc Lung Dis. 2022;26:142-149.
PubMed Abstract available

LOPEZ-VARELA E, Garcia-Prats AJ, Seddon JA, Draper HR, et al
Treatment outcomes and safety in children with rifampicin-resistant TB.
Int J Tuberc Lung Dis. 2022;26:133-141.
PubMed Abstract available

BURHAN E, Soepandi PZ, Isbaniah F, Damayanti K, et al
Determinants of treatment outcomes in patients with multidrug-resistant TB.
Int J Tuberc Lung Dis. 2022;26:126-132.
PubMed Abstract available

HOSSAIN MD, Rahim MA, Islam N, Afroze F, et al
TB prevalence among patients with diabetes in Bangladesh.
Int J Tuberc Lung Dis. 2022;26:119-125.
PubMed Abstract available

KHAWCHAROENPORN T, Noisang K
Incomplete contact investigation and risk of developing TB among healthcare professionals.
Int J Tuberc Lung Dis. 2022;26:111-118.
PubMed Abstract available

APRIANI L, Koesoemadinata RC, Bastos ML, Wulandari DA, et al
Implementing the 4R and 9H regimens for TB preventive treatment in Indonesia.
Int J Tuberc Lung Dis. 2022;26:103-110.
PubMed Abstract available

ILAIWY G, Heysell SK, Thomas TA
National approaches to TB care in adolescents.
Int J Tuberc Lung Dis. 2022;26:96-102.
PubMed Abstract available

SILVA DR, de Queiroz Mello FC
Improving outcomes for multidrug-resistant TB treatment.
Int J Tuberc Lung Dis. 2022;26:93-95.
PubMed

BARRETT J
Why are people still dying from TB in low-burden countries?
Int J Tuberc Lung Dis. 2022;26:91-92.
PubMed

HARRIES AD, Zellweger JP
Protecting healthcare workers from TB.
Int J Tuberc Lung Dis. 2022;26:89-90.
PubMed

GRAHAM SM, Amanullah F
Updated guidelines for child and adolescent TB.
Int J Tuberc Lung Dis. 2022;26:81-84.
PubMed

LANGE C, Kay A, Mandalakas AM
The need for effective drugs for TB prevention: set your goals high, and don t stop till you get there.
Int J Tuberc Lung Dis. 2022;26:85-88.
PubMed

January 2022

TADOLINI M, Onozaki I
National TB prevalence surveys in the COVID-19 era.
Int J Tuberc Lung Dis. 2022;26:4-5.
PubMed

SINHA P, White LF, Hochberg NS, Cegielski JP, et al
Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB.
Int J Tuberc Lung Dis. 2022;26:80.
PubMed

KLAOS K, Holicka Y, Groenheit R, Kodmon C, et al
Current state of national TB laboratory networks in Europe: achievements and challenges.
Int J Tuberc Lung Dis. 2022;26:71-73.
PubMed

OJUAWO O, Piracha S, Irshad S, Mirza M, et al
Tuberculous mastitis in a low-incidence setting: should respiratory physicians be concerned?
Int J Tuberc Lung Dis. 2022;26:69-70.
PubMed

PETRUCCIOLI E, Farroni C, Cuzzi G, Vanini V, et al
VIDAS((R)) TB-IGRA reagents induce a CD4(+) and CD8(+) T-cell IFN-gamma response for both TB infection and active TB.
Int J Tuberc Lung Dis. 2022;26:65-68.
PubMed

CHIPINDURO M, Timire C, Chirenda J, Matambo R, et al
TB prevalence in Zimbabwe: a national cross-sectional survey, 2014.
Int J Tuberc Lung Dis. 2022;26:57-64.
PubMed Abstract available

ACOSTA J, Flores P, Alarcon M, Grande-Ortiz M, et al
A randomised controlled trial to evaluate a medication monitoring system for TB treatment.
Int J Tuberc Lung Dis. 2022;26:44-49.
PubMed Abstract available

December 2021

ZAMANI S, Honarvar MR, Behnampour N, Sheikhy M, et al
Decline in TB incidence during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2021;25:1043-1044.
PubMed

SUMNER T, Fiore-Gartland A, Hatherill M, Houben RMGJ, et al
The effect of new Mycobacterium tuberculosis infection on the sensitivity of prognostic TB signatures.
Int J Tuberc Lung Dis. 2021;25:1001-1005.
PubMed Abstract available

SARDA R, Ray A
Pulmonary TB and chronic pulmonary aspergillosis.
Int J Tuberc Lung Dis. 2021;25:1042-1043.
PubMed

TESFAHUN H, Moussally K, Al-Ani NA, Al-Salhi LG, et al
Introduction of new drugs for drug-resistant TB in Iraq.
Int J Tuberc Lung Dis. 2021;25:1041-1042.
PubMed

CHATTERJEE S, Toshniwal MN, Bhide P, Sachdeva KS, et al
Costs of TB services in India (No 1).
Int J Tuberc Lung Dis. 2021;25:1013-1018.
PubMed Abstract available

ZHU H, Xie L, Liu ZQ, Wang B, et al
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:1006-1012.
PubMed Abstract available

NIKOLENKA A, Mansjo M, Skrahina A, Hurevich H, et al
Whole-genome sequencing differentiates relapse from re-infection in TB.
Int J Tuberc Lung Dis. 2021;25:995-1000.
PubMed Abstract available

LEE JJ, Kang HY, Lee WI, Cho SY, et al
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:974-981.
PubMed Abstract available

TELISINGHE L, Shaweno D, Hayes RJ, Dodd PJ, et al
The effect of systematic screening of the general population on TB case notification rates.
Int J Tuberc Lung Dis. 2021;25:964-973.
PubMed Abstract available

November 2021

ANTONY S, Bodhanwala M, Shah I
Clinical profile and outcomes of paediatric central nervous system tuberculomas.
Int J Tuberc Lung Dis. 2021;25:953-955.
PubMed

FUKUSHIMA K, Akagi K, Kondoh A, Kubo T, et al
Evaluation of QFT-Plus performance using blood samples stored at room temperature.
Int J Tuberc Lung Dis. 2021;25:948-949.
PubMed

WOLTERS BA, Aartsma Y, Jansen K, van Hest R, et al
Travel history and challenges of screening for latent TB infection in child asylum seekers.
Int J Tuberc Lung Dis. 2021;25:945-947.
PubMed

CHRISTOPHER DJ, Coelho V, Ebby GS, Shankar D, et al
Incremental yield of Xpert((R)) MTB/RIF Ultra over Xpert((R)) MTB/RIF in the diagnosis of extrapulmonary TB.
Int J Tuberc Lung Dis. 2021;25:939-944.
PubMed Abstract available

GATECHOMPOL S, Sophonphan J, Kerr SJ, Ubolyam S, et al
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV.
Int J Tuberc Lung Dis. 2021;25:933-938.
PubMed Abstract available

KASWA M, Minga G, Nkiere N, Mingiedi B, et al
The economic burden of TB-affected households in DR Congo.
Int J Tuberc Lung Dis. 2021;25:923-932.
PubMed Abstract available

STIEBER F, Howard J, Manissero D, Boyle J, et al
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis.
Int J Tuberc Lung Dis. 2021;25:917-922.
PubMed Abstract available

MURITHI W, Click ES, McCarthy KD, Okeyo E, et al
Need for caution when interpreting Xpert((R)) MTB/RIF results for rifampin resistance among children.
Int J Tuberc Lung Dis. 2021;25:911-916.
PubMed Abstract available

LUAN L, Fraisse P, Cordel H, Charlois C, et al
Screening for active and latent TB among migrants in France.
Int J Tuberc Lung Dis. 2021;25:903-910.
PubMed Abstract available

WINCKLER JL, Schaaf HS, Draper HR, McIlleron H, et al
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:896-902.
PubMed Abstract available

TAAFFE J, Croda J, Moultrie H, Silva DS, et al
Advancing TB research using digitized programmatic data.
Int J Tuberc Lung Dis. 2021;25:890-895.
PubMed Abstract available

BOEREE MJ, Lange C, Thwaites G, Paton N, et al
UNITE4TB: a new consortium for clinical drug and regimen development for TB.
Int J Tuberc Lung Dis. 2021;25:886-889.
PubMed

OCHERETINA O, Brandao AP, Pang Y, Rodrigues C, et al
Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert((R)) MTB/RIF.
Int J Tuberc Lung Dis. 2021;25:881-885.
PubMed

ALFFENAAR JC, Marais BJ, Thomas TA
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?
Int J Tuberc Lung Dis. 2021;25:879-880.
PubMed

October 2021

SEKANDI JN, Tucker EG, Zalwango S, Buregyeya E, et al
Digital technologies and loss to follow-up for TB patients.
Int J Tuberc Lung Dis. 2021;25:871-872.
PubMed

HASSAN L, Ali SM, Iqbal W, Baig S, et al
Automated detection and reduction of stigma in online discussions about TB.
Int J Tuberc Lung Dis. 2021;25:869-870.
PubMed

ARENAS-MIRAS M, Sanchez-Martinez F, Jove-Caballe N, Villar-Garcia J, et al
Clinical experience of TB in patients treated with anti-TNF-alpha.
Int J Tuberc Lung Dis. 2021;25:866-868.
PubMed

TAHSEEN S, Khanzada FM, Hussain A, Akhtar N, et al
Phenotypic vs. genotypic resistance to fluoroquinolones in rifampicin-resistant TB.
Int J Tuberc Lung Dis. 2021;25:861-863.
PubMed

EJO M, Van Deun A, Nunn A, Meredith S, et al
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial.
Int J Tuberc Lung Dis. 2021;25:839-845.
PubMed Abstract available

BLACK M, Da Silva P, Scott L
Rifampicin-resistant TB: discordance between Xpert((R)) MTB/RIF and MTBDRplus results.
Int J Tuberc Lung Dis. 2021;25:832-838.
PubMed Abstract available

OXLADE O, den Boon S, Menzies D, Falzon D, et al
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up.
Int J Tuberc Lung Dis. 2021;25:823-831.
PubMed Abstract available

PURCHASE S, Batist E, Mmile N, Nkosi S, et al
Challenges in recruiting children to a multidrug-resistant TB prevention trial.
Int J Tuberc Lung Dis. 2021;25:814-822.
PubMed Abstract available

September 2021

KOZINSKA M, Podlasin R, Ropelewska-Lacka K, Wojtycha-Kwasnica B, et al
TB and COVID-19 coinfection.
Int J Tuberc Lung Dis. 2021;25:776-777.
PubMed

MOHR-HOLLAND E, Hacking D, Daniels J, Scott V, et al
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19.
Int J Tuberc Lung Dis. 2021;25:772-775.
PubMed

GIGANTE AR, Sousa M, Aguiar A, Pinto M, et al
The impact of COVID-19 on the TB response: data from the field.
Int J Tuberc Lung Dis. 2021;25:769-771.
PubMed

SHIN JE, Jo KW, O YJ, Jeon D, et al
Impact of revised definitions for extensively drug-resistant TB on disease classification.
Int J Tuberc Lung Dis. 2021;25:766-768.
PubMed

GUTIERREZ A, Isidro A, Herrerin J, Hinojosa J, et al
Meningeal TB in a mummified child from 4,000 years ago.
Int J Tuberc Lung Dis. 2021;25:761-762.
PubMed

KAMOLWAT P, Nonghanphithak D, Chaiprasert A, Smithtikarn S, et al
Diagnostic performance of whole-genome sequencing for identifying drug-resistant TB in Thailand.
Int J Tuberc Lung Dis. 2021;25:754-760.
PubMed Abstract available

HUDDART S, Ingawale P, Edwin J, Jondhale V, et al
TB case fatality and recurrence in a private sector cohort in Mumbai, India.
Int J Tuberc Lung Dis. 2021;25:738-746.
PubMed Abstract available

MOODLIAR R, Aksenova V, Frias MVG, van de Logt J, et al
Bedaquiline for multidrug-resistant TB in paediatric patients.
Int J Tuberc Lung Dis. 2021;25:716-724.
PubMed Abstract available

MURPHY RA, Douglas-Jones B, Mucinya G, Sunpath H, et al
Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:696-700.
PubMed Abstract available

CHESOV D, Makhanda G, Furin J
Tackling the many layers of stigma is essential for the "End TB Strategy".
Int J Tuberc Lung Dis. 2021;25:683-684.
PubMed

August 2021

RANAIVOMANANA P, Knoblauch AM, Razafimahatratra MC, Raherinandrasana AH, et al
Pulmonary and pleural TB prevalence in pregnant women.
Int J Tuberc Lung Dis. 2021;25:668-670.
PubMed

EDDY JJ, Seth B, White LF, Sulis CA, et al
Decreasing time spent in airborne infection isolation during TB testing.
Int J Tuberc Lung Dis. 2021;25:665-667.
PubMed

CLARKSON MC, McQuaid CF, Houben RM, Kranzer K, et al
Better data for country-level TB resource allocation are urgently required.
Int J Tuberc Lung Dis. 2021;25:662-664.
PubMed

PERRY A, Chitnis A, Chin A, Hoffmann C, et al
Real-world implementation of video-observed therapy in an urban TB program in the United States.
Int J Tuberc Lung Dis. 2021;25:655-661.
PubMed Abstract available

SMITH AGC, Gujabidze M, Avaliani T, Blumberg HM, et al
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens.
Int J Tuberc Lung Dis. 2021;25:632-639.
PubMed Abstract available

SHARMA K, Sharma M, Modi M, Singla N, et al
Comparative analysis of Truenat MTB Plus and Xpert((R)) Ultra in diagnosing tuberculous meningitis.
Int J Tuberc Lung Dis. 2021;25:626-631.
PubMed Abstract available

CAMPBELL JR, Katamba A, Oxlade O, Schwartzman K, et al
Improving country-level modelling to support TB prevention and care.
Int J Tuberc Lung Dis. 2021;25:607-608.
PubMed

DONOVAN J, Walker TM
Diagnosing tuberculous meningitis: a testing process.
Int J Tuberc Lung Dis. 2021;25:605-606.
PubMed

July 2021

AMOUR M, von Reyn CF
A new paradigm: testing household contacts of adolescents with incident TB infection.
Int J Tuberc Lung Dis. 2021;25:599b-600.
PubMed

RODRIGUEZ CA, Brooks MB, Aibana O, Mitnick CD, et al
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:596-598.
PubMed

ERISA KC, Robsky KO, Kitonsa PJ, Nalutaaya A, et al
Low prevalence of diabetes mellitus in TB patients and the community in urban Uganda.
Int J Tuberc Lung Dis. 2021;25:590-592.
PubMed

DOUGLAS-JONES B, Mohr-Holland E, Mema N, Mathee S, et al
A home-based care programme for rifampicin-resistant TB.
Int J Tuberc Lung Dis. 2021;25:587-589.
PubMed

HABIB SS, Malik AA, Khan U, Khowaja S, et al
Impact of upfront Xpert testing on time to treatment initiation for multidrug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:584-586.
PubMed

MORAN A, Lebona L, Makgopa G, Nkwane Y, et al
One size does not fit all: reaching agricultural workers in South Africa with TB services.
Int J Tuberc Lung Dis. 2021;25:573-578.
PubMed Abstract available

YANGTHARA B, Wutthigate P, Roongmaitree S, Siripattanapipong P, et al
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes.
Int J Tuberc Lung Dis. 2021;25:567-572.
PubMed Abstract available

BLACK DA, McBrien SW, Gersh J, Ghassemieh B, et al
TB risk by time since U.S. entry among non-U.S.-born residents of Washington State, USA.
Int J Tuberc Lung Dis. 2021;25:560-566.
PubMed Abstract available

FEUTH T, Patovirta RL, Grierson S, Danilovits M, et al
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines.
Int J Tuberc Lung Dis. 2021;25:554-559.
PubMed Abstract available

LARGEN A, Ayala A, Khurana R, Katz DJ, et al
Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection.
Int J Tuberc Lung Dis. 2021;25:547-553.
PubMed Abstract available

BALUKU JB, Nuwagira E, Bongomin F, Denning DW, et al
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities.
Int J Tuberc Lung Dis. 2021;25:537-546.
PubMed Abstract available

SHARMA M, Onozaki I, Nunn P
TB in older people in Asia: why it is important.
Int J Tuberc Lung Dis. 2021;25:521-524.
PubMed

SALZER HJF, Wang JY
Chronic pulmonary aspergillosis as a sequel to pulmonary TB.
Int J Tuberc Lung Dis. 2021;25:519-520.
PubMed

June 2021

AGOSTINIS A, Heffernan C, Long R, Beckon A, et al
Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities.
Int J Tuberc Lung Dis. 2021;25:447-452.
PubMed Abstract available

TEO AKJ, Ong CWM, Hsu LY
COVID-19 and TB: a progression-regression conundrum.
Int J Tuberc Lung Dis. 2021;25:421-423.
PubMed

BASHAM CA, Romanowski K, Johnston JC
Alcohol use disorder and TB survivor health.
Int J Tuberc Lung Dis. 2021;25:516-517.
PubMed

MANTSHONYANE L, Kgwaadira B, Gross R
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB.
Int J Tuberc Lung Dis. 2021;25:511-512.
PubMed

ROYCROFT E, Fitzgibbon MM, Kelly DM, Scully M, et al
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing.
Int J Tuberc Lung Dis. 2021;25:491-497.
PubMed Abstract available

SZKWARKO D, Amisi JA, Peterson D, Burudi S, et al
Using a mobile application to improve pediatric presumptive TB identification in western Kenya.
Int J Tuberc Lung Dis. 2021;25:468-474.
PubMed Abstract available

REDWOOD L, Mitchell EMH, Viney K, Snow K, et al
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam.
Int J Tuberc Lung Dis. 2021;25:461-467.
PubMed Abstract available

OELOFSE S, Esmail A, Diacon AH, Conradie F, et al
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts.
Int J Tuberc Lung Dis. 2021;25:453-460.
PubMed Abstract available

CHAISSON LH, Naufal F, Delgado-Barroso P, Alvarez-Manzo HS, et al
A systematic review of the number needed to screen for active TB among people living with HIV.
Int J Tuberc Lung Dis. 2021;25:427-435.
PubMed Abstract available

TAVOSCHI L, Toscanini F, Pontali E
TB and prisons: confinement does not contain the disease.
Int J Tuberc Lung Dis. 2021;25:424-426.
PubMed

AKKERMAN OW, Tiberi S, Alffenaar JW
Shortening MDR-TB treatment: is treating more patients with fewer drugs better?
Int J Tuberc Lung Dis. 2021;25:419-420.
PubMed

May 2021

ZOKUFA N, Lebelo K, Hacking D, Tabo L, et al
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era.
Int J Tuberc Lung Dis. 2021;25:406-408.
PubMed

POLLOCK NR, MacIntyre AT, Blauwkamp TA, Blair L, et al
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients.
Int J Tuberc Lung Dis. 2021;25:403-405.
PubMed

MIN J, Kang JY, Kim J, Yang J, et al
Impact of COVID-19 on TB services in Korea.
Int J Tuberc Lung Dis. 2021;25:400-402.
PubMed

MARGINEANU I, Mor Z, Garcia D, Gilpin C, et al
TB and COVID-19 in migrants - the need to focus on both conditions.
Int J Tuberc Lung Dis. 2021;25:333-335.
PubMed

MCQUAID CF, Foster N, Quaife M, Levy J, et al
Digital adherence technology for TB: focus on livelihoods as well as lives.
Int J Tuberc Lung Dis. 2021;25:416-417.
PubMed

RICCARDI N, Saderi L, Borroni E, Tagliani E, et al
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study.
Int J Tuberc Lung Dis. 2021;25:395-399.
PubMed Abstract available

KALEMA N, Semeere A, Banturaki G, Kyamugabwa A, et al
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis.
Int J Tuberc Lung Dis. 2021;25:388-394.
PubMed Abstract available

SATYANARAYANA S, Bhatia V, Mandal PP, Kanchar A, et al
Urgent need to address the slow scale-up of TB preventive treatment in the WHO South-East Asia Region.
Int J Tuberc Lung Dis. 2021;25:382-387.
PubMed Abstract available

FERREIRO L, Ruano-Ravina A, Otero-Mallo R, Pou-Alvarez C, et al
Recent epidemiological trends in extrapulmonary TB in Galicia, Spain.
Int J Tuberc Lung Dis. 2021;25:373-381.
PubMed Abstract available

WEYENGA H, Karanja M, Onyango E, Katana AK, et al
Can isoniazid preventive therapy be scaled up rapidly? Lessons learned in Kenya, 2014-2018.
Int J Tuberc Lung Dis. 2021;25:367-372.
PubMed Abstract available

MARTSON AG, Kim HY, Marais B, Alffenaar JW, et al
The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment.
Int J Tuberc Lung Dis. 2021;25:336-339.
PubMed

April 2021

MALABAD JCM, Ang CF, Palabrica FAR, Cajucom MAM, et al
Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients.
Int J Tuberc Lung Dis. 2021;25:285-291.
PubMed Abstract available

HARRIES AD, Kumar AMV, Satyanarayana S, Thekkur P, et al
TB and COVID-19: measuring key risk factors that affect treatment outcomes.
Int J Tuberc Lung Dis. 2021;25:329-331.
PubMed

COX V, Guglielmetti L, Hewison C, Reuter A, et al
Reply to: "Human rights: finding the right balance for rifampicin-resistant TB treatment".
Int J Tuberc Lung Dis. 2021;25:328-329.
PubMed

VAN DEUN A, Piubello A, Lynen L, de Jong BC, et al
Human rights: finding the right balance for rifampicin-resistant TB treatment.
Int J Tuberc Lung Dis. 2021;25:327-328.
PubMed

GULLON-BLANCO JA, Rodrigo-Sanz T, Alvarez-Navascues F, Tabernero-Huguet E, et al
Completion of treatment for latent TB infection in a low prevalence setting.
Int J Tuberc Lung Dis. 2021;25:321-323.
PubMed

ROY N, Krishnamoorthy Y, Rajaa S, Ezhumalai K, et al
Health-related quality of life and its effect on TB treatment outcomes.
Int J Tuberc Lung Dis. 2021;25:318-320.
PubMed

BHERING M, Duarte R, Kritski A
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil.
Int J Tuberc Lung Dis. 2021;25:292-298.
PubMed Abstract available

CHESOV D, Butov D, Reimann M, Heyckendorf J, et al
Impact of lung function on treatment outcome in patients with TB.
Int J Tuberc Lung Dis. 2021;25:277-284.
PubMed Abstract available

VISCA D, D Ambrosio L, Centis R, Pontali E, et al
Post-TB disease: a new topic for investigation-and why it matters.
Int J Tuberc Lung Dis. 2021;25:258-261.
PubMed

LAU A, Ferrara G
Disseminated TB: still being missed and misunderstood.
Int J Tuberc Lung Dis. 2021;25:255-257.
PubMed

SCHULTINK MP, Kerstjens HAM, Ter Beek L, Zondag H, et al
Assessment of TB treatment on patient well-being.
Int J Tuberc Lung Dis. 2021;25:315-317.
PubMed

March 2021

KUMAR MS, Surendran D, Manu MS, Rakesh PS, et al
Mortality due to TB-COVID-19 coinfection in India.
Int J Tuberc Lung Dis. 2021;25:250-251.
PubMed

GRACIAA DS, Kempker RR, Sanikidze E, Tukvadze S, et al
TB research amidst the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2021;25:167-170.
PubMed

ALLWOOD BW, van der Zalm MM, Mortimer K
Reply to "Clinical care for patients with post TB lung disease".
Int J Tuberc Lung Dis. 2021;25:253-254.
PubMed

GUNTHER G, Ithete S
Clinical care for patients with post-TB lung disease.
Int J Tuberc Lung Dis. 2021;25:252-253.
PubMed

PARK JH, Jung J, Kim JY, Hong MJ, et al
Airborne precautions based on Xpert((R)) MTB/RIF results for patients with presumptive TB.
Int J Tuberc Lung Dis. 2021;25:244-246.
PubMed

KIZNY GORDON A, Tong SYC, Martinez E, Crighton T, et al
TB genomic surveillance and data sharing in recognising contamination events.
Int J Tuberc Lung Dis. 2021;25:241-243.
PubMed

BAIK Y, Nalutaaya A, Kitonsa PJ, Dowdy DW, et al
Infection status of contacts is not associated with severity of TB in the index case.
Int J Tuberc Lung Dis. 2021;25:237-240.
PubMed

ADANKWAH E, Arthur RA, Minadzi D, Owusu DO, et al
Immune response against TB and non-tuberculous mycobacterial pulmonary disease.
Int J Tuberc Lung Dis. 2021;25:234-236.
PubMed

MALIK AA, Fuad J, Abbass W, Ikhlaque S, et al
Preventive treatment of drug-resistant TB in a rural setting.
Int J Tuberc Lung Dis. 2021;25:231-233.
PubMed

CATES L, Crudu V, Codreanu A, Ciobanu N, et al
Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting.
Int J Tuberc Lung Dis. 2021;25:228-230.
PubMed

COX SR, Gupte AN, Thomas B, Gaikwad S, et al
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men.
Int J Tuberc Lung Dis. 2021;25:182-190.
PubMed Abstract available

SOHN H, Sweeney S, Mudzengi D, Creswell J, et al
Determining the value of TB active case-finding: current evidence and methodological considerations.
Int J Tuberc Lung Dis. 2021;25:171-181.
PubMed Abstract available

February 2021

BARRETT J, Painter H, Rajgopal A, Keane D, et al
Increase in disseminated TB during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2021;25:160-166.
PubMed

ALLWOOD BW, van der Zalm MM, Mortimer K
Reply to: Taking action to improve post-TB lung health.
Int J Tuberc Lung Dis. 2021;25:163a-163.
PubMed

HARRIES AD, Dlodlo RA, Brigden G, Chakaya JM, et al
Taking action to improve post-TB lung health.
Int J Tuberc Lung Dis. 2021;25:161-162.
PubMed

MOLINA-MOYA B, Guglielmetti L, Bothamley G, van Leth F, et al
Use and impact of molecular methods for detecting drug-resistant TB.
Int J Tuberc Lung Dis. 2021;25:157-159.
PubMed

LAW WS, Chan CKA, Leung CC
Management of latent TB infection in child household contacts aged under 5 years.
Int J Tuberc Lung Dis. 2021;25:151-153.
PubMed

MEHTA SN, Murrill M, Suryavanshi N, Bhosale R, et al
TB-related knowledge and stigma among pregnant women in low-resource settings.
Int J Tuberc Lung Dis. 2021;25:148-150.
PubMed

ARSCOTT-MILLS T, Ejelonu A, Mokalane K, Machao G, et al
One third of child TB cases were missing from the national TB register in Botswana.
Int J Tuberc Lung Dis. 2021;25:142-144.
PubMed

DE VOS E, Scott L, Voss De Lima Y, Warren RM, et al
Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.
Int J Tuberc Lung Dis. 2021;25:134-141.
PubMed Abstract available

SOTGIU G, Rosales-Klintz S, Centis R, D'Ambrosio L, et al
TB management in the European Union/European Economic Area: a multi-centre survey.
Int J Tuberc Lung Dis. 2021;25:126-133.
PubMed Abstract available

FOX GJ, Johnston JC, Nguyen TA, Majumdar SS, et al
Active case-finding in contacts of people with TB.
Int J Tuberc Lung Dis. 2021;25:95-105.
PubMed Abstract available

LINH NN, Miller C, Marks GB
Potential benefits of active case finding to reduce the burden of TB.
Int J Tuberc Lung Dis. 2021;25:93-94.
PubMed

January 2021

SHEN X, Sha W, Yang C, Pan Q, et al
Continuity of TB services during the COVID-19 pandemic in China.
Int J Tuberc Lung Dis. 2021;25:81-83.
PubMed

TB and COVID-19 co-infection: rationale and aims of a global study.
Int J Tuberc Lung Dis. 2021;25:78-80.
PubMed

MAUG AKJ, Hossain MA, Gumusboga M, Decroo T, et al
Finding the right balance between efficacy and tolerability for TB treatment: the search continues.
Int J Tuberc Lung Dis. 2021;25:84-86.
PubMed

PARIGI S, Venturini E, Galli L, Chiappini E, et al
Xpert((R)) MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates.
Int J Tuberc Lung Dis. 2021;25:75-77.
PubMed

SAKR CJ, Musharrafieh UM, Banna HS, Hoteit RA, et al
Risks and benefits of QuantiFERON((R))-TB testing for LTBI screening of health workers.
Int J Tuberc Lung Dis. 2021;25:72-74.
PubMed

GENDERINI FG, Dauby N, Delforge M, De Wit S, et al
TB in the intensive care unit in a low-endemic country.
Int J Tuberc Lung Dis. 2021;25:69-71.
PubMed

NABISERE R, Arinaitwe A, Muyise R, Asienzo J, et al
Implementation of TB preventive therapy in Uganda: effect of an intervention on completion rates.
Int J Tuberc Lung Dis. 2021;25:64-65.
PubMed

TUCKER A, Oyuku D, Nalugwa T, Nantale M, et al
Costs along the TB diagnostic pathway in Uganda.
Int J Tuberc Lung Dis. 2021;25:61-63.
PubMed

MAVE V, Kadam D, Gaikwad S, Kinikar A, et al
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes.
Int J Tuberc Lung Dis. 2021;25:52-60.
PubMed Abstract available

MESFIN AB, Araia ZZ, Beyene HN, Mebrahtu AH, et al
First molecular-based anti-TB drug resistance survey in Eritrea.
Int J Tuberc Lung Dis. 2021;25:43-51.
PubMed Abstract available

SENEADZA NAH, Antwi S, Yang H, Enimil A, et al
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children.
Int J Tuberc Lung Dis. 2021;25:36-42.
PubMed Abstract available

WROHAN I, Redwood L, Ho J, Velen K, et al
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2021;25:23-30.
PubMed Abstract available

SOH AZ, Tan CTY, Mok E, Chee CBE, et al
Adipokines and the risk of active TB: a nested case-control study.
Int J Tuberc Lung Dis. 2021;25:31-35.
PubMed Abstract available

December 2020

ZHANG H, Cao X, Wang D, Xin H, et al
The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study.
Int J Tuberc Lung Dis. 2020;24:1241-1246.
PubMed Abstract available

FANG JL, Chao CM, Tang HJ
The impact of COVID-19 on the diagnosis of TB in Taiwan.
Int J Tuberc Lung Dis. 2020;24:1321-1322.
PubMed

SINGH J, Ehtesham NZ, Hasnain SE
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB.
Int J Tuberc Lung Dis. 2020;24:1319-1320.
PubMed

November 2020

FATIMA R, Yaqoob A
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes.
Int J Tuberc Lung Dis. 2020;24:1227-1228.
PubMed

DE SOUZA CDF, Coutinho HS, Costa MM, Magalhaes MAFM, et al
Impact of COVID-19 on TB diagnosis in Northeastern Brazil.
Int J Tuberc Lung Dis. 2020;24:1220-1222.
PubMed

ZHOU S, Van Staden Q, Toska E
Resource reprioritisation amid competing health risks for TB and COVID-19.
Int J Tuberc Lung Dis. 2020;24:1215-1216.
PubMed

KADOTA JL, Reza TF, Nalugwa T, Kityamuwesi A, et al
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2020;24:1212-1214.
PubMed

HAAS MK, Ignatius EH, Stout JE, Dooley KE, et al
Finding the right balance between efficacy and tolerability for TB treatment.
Int J Tuberc Lung Dis. 2020;24:1225b-1226.
PubMed

WANG EY, Ahluwalia IB, Mase SR
Response to Correspondence: The impact of smoking on TB treatment outcomes includes recurrent TB.
Int J Tuberc Lung Dis. 2020;24:1225a-1225.
PubMed

DHAMGAYE TM
In reply: Latent TB treatment in pregnant women: a patient perspective.
Int J Tuberc Lung Dis. 2020;24:1226-1227.
PubMed

CHIANG CY, Bam TS
The impact of smoking on TB treatment outcomes includes recurrent TB.
Int J Tuberc Lung Dis. 2020;24:1224-1225.
PubMed

October 2020

KIM HW, Min J, Shin AY, Koo HK, et al
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study.
Int J Tuberc Lung Dis. 2020;24:1016-1023.
PubMed Abstract available

SHAHRIARIRAD R, Fallahi MJ
TB and the COVID-19 pandemic: brothers in arms against lung health.
Int J Tuberc Lung Dis. 2020;24:1126-1127.
PubMed

WU Z, Chen J, Xia Z, Pan Q, et al
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China.
Int J Tuberc Lung Dis. 2020;24:1122-1124.
PubMed

MENEGUIM AC, Rebello L, Das M, Ravi S, et al
Adapting TB services during the COVID-19 pandemic in Mumbai, India.
Int J Tuberc Lung Dis. 2020;24:1119-1121.
PubMed

HELDAL E, Dlodlo RA
Estimating subnational TB burden-why not strengthen and use routine recording and reporting?
Int J Tuberc Lung Dis. 2020;24:1125-1127.
PubMed

AKKERMAN OW, Tiberi S
The importance of knowing why TB patients stop anti-TB treatment.
Int J Tuberc Lung Dis. 2020;24:989-990.
PubMed

September 2020

YASSIN M, Grzemska M
Response to 'The Green Light Committee could contribute to ending tuberculosis .
Int J Tuberc Lung Dis. 2020;24:984.
PubMed

NGUYEN TBP, Nguyen TA, Luu BK, Le TTO, et al
A comparison of digital chest radiography and Xpert((R)) MTB/RIF in active case finding for tuberculosis.
Int J Tuberc Lung Dis. 2020;24:934-940.
PubMed Abstract available

CHIANG CH, Lee GH, Chiang TH, Tang PU, et al
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients.
Int J Tuberc Lung Dis. 2020;24:922-927.
PubMed Abstract available

LOVEDAY M, Hlangu S, Furin J
Breastfeeding in women living with tuberculosis.
Int J Tuberc Lung Dis. 2020;24:880-891.
PubMed Abstract available

ADEWOLE OO
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria.
Int J Tuberc Lung Dis. 2020;24:981-982.
PubMed

VAN DER WALT M, Keddy KH
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease.
Int J Tuberc Lung Dis. 2020;24:978-980.
PubMed

WILSON FA, Miller TL, Stimpson JP
COVID-19 and TB control in immigrant communities.
Int J Tuberc Lung Dis. 2020;24:975-977.
PubMed

ECHEVERRIA G, Espinoza W, de Waard JH
How TB and COVID-19 compare: an opportunity to integrate both control programmes.
Int J Tuberc Lung Dis. 2020;24:971-974.
PubMed

MULDER C, Nkiligi E, Kondo Z, Scholten JN, et al
What to look for when using SUBsET for subnational TB incidence estimates.
Int J Tuberc Lung Dis. 2020;24:983-984.
PubMed

WANG J, Garcia-Basteiro AL
Should vitamin D supplementation be used concomitantly with LTBI treatment?
Int J Tuberc Lung Dis. 2020;24:875-876.
PubMed

August 2020

KOURA KG, Harries AD, Fujiwara PI, Dlodlo RA, et al
COVID-19 in Africa: community and digital technologies for tuberculosis management.
Int J Tuberc Lung Dis. 2020;24:863-865.
PubMed

LOUIE JK, Reid M, Stella J, Agraz-Lara R, et al
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2020;24:860-862.
PubMed

DEWI IMW, Soeroto AY, Putriyani G, Hanifah W, et al
Aspergillus fumigatus-specific antibodies in patients with chronic tuberculosis.
Int J Tuberc Lung Dis. 2020;24:853-856.
PubMed

SILVA LL, Valverde TL, de Carvalho Dutra A, De Andrade L, et al
Geospatial analysis and factors associated with poor outcome for multidrug-resistant tuberculosis.
Int J Tuberc Lung Dis. 2020;24:844-846.
PubMed

ALLWOOD BW, van der Zalm MM, Amaral AFS, Byrne A, et al
Post-tuberculosis lung health: perspectives from the First International Symposium.
Int J Tuberc Lung Dis. 2020;24:820-828.
PubMed Abstract available

CHIMEH RA, Gafar F, Pradipta IS, Akkerman OW, et al
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review.
Int J Tuberc Lung Dis. 2020;24:811-819.
PubMed Abstract available

SIAPKA M, Vassall A, Cunnama L, Pineda C, et al
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression.
Int J Tuberc Lung Dis. 2020;24:802-810.
PubMed Abstract available

HAN X, Chen X, Sha W, Zhang X, et al
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis in China.
Int J Tuberc Lung Dis. 2020;24:789-794.
PubMed Abstract available

MCARDLE AJ, Keane D, Seddon JA, Bernatoniene J, et al
Vitamin D deficiency is associated with tuberculosis disease in British children.
Int J Tuberc Lung Dis. 2020;24:782-788.
PubMed Abstract available

VISCA D, Centis R, Munoz-Torrico M, Pontali E, et al
Post-tuberculosis sequelae: the need to look beyond treatment outcome.
Int J Tuberc Lung Dis. 2020;24:761-762.
PubMed

ZUMLA A, Marais BJ, McHugh TD, Maeurer M, et al
COVID-19 and tuberculosis-threats and opportunities.
Int J Tuberc Lung Dis. 2020;24:757-760.
PubMed

JAMAL WZ, Habib S, Khowaja S, Safdar N, et al
COVID-19: ensuring continuity of TB services in the private sector.
Int J Tuberc Lung Dis. 2020;24:870-872.
PubMed

WATTS K, McKeown A, Denholm J, Baker AM, et al
Responding to COVID-19: adjusting TB services in a low-burden setting.
Int J Tuberc Lung Dis. 2020;24:866-869.
PubMed

CHIANG CY
Green Light Committee and WHO recommendations.
Int J Tuberc Lung Dis. 2020;24:873-874.
PubMed

July 2020

KUBIAK RW, Drain PK, Hochberg NS
How should body mass index inform active tuberculosis screening in diabetes clinics in Asia?
Int J Tuberc Lung Dis. 2020;24:753.
PubMed

LIU C, Yu Y, Fleming J, Wang T, et al
Severe COVID-19 cases with a history of active or latent tuberculosis.
Int J Tuberc Lung Dis. 2020;24:747-749.
PubMed

BURZYNSKI J, Macaraig M, Nilsen D, Schluger NW, et al
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City.
Int J Tuberc Lung Dis. 2020;24:735-736.
PubMed

KADOTA JL, Katamba A, Musinguzi A, Welishe F, et al
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy.
Int J Tuberc Lung Dis. 2020;24:729-731.
PubMed

CHIANG SS, Beckhorn CB, Wong M, Lecca L, et al
Patterns of suboptimal adherence among adolescents treated for tuberculosis.
Int J Tuberc Lung Dis. 2020;24:723-725.
PubMed

VISCA D, Centis R, D'Ambrosio L, Munoz-Torrico M, et al
The need for pulmonary rehabilitation following tuberculosis treatment.
Int J Tuberc Lung Dis. 2020;24:720-722.
PubMed

EDWARDS T, White LV, Lee N, Castro MC, et al
Effects of comorbidities on quality of life in Filipino people with tuberculosis.
Int J Tuberc Lung Dis. 2020;24:712-719.
PubMed Abstract available

IQBAL SA, Isenhour CJ, Mazurek G, Truman BI, et al
Diagnostic code agreement for electronic health records and claims data for tuberculosis.
Int J Tuberc Lung Dis. 2020;24:706-711.
PubMed Abstract available

MUNOZ-TORRICO M, Cid-Juarez S, Gochicoa-Rangel L, Torre-Bouscolet L, et al
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis.
Int J Tuberc Lung Dis. 2020;24:700-705.
PubMed Abstract available

WATTHANANUKUL T, Liabsuetrakul T, Pungrassami P, Chongsuvivatwong V, et al
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis.
Int J Tuberc Lung Dis. 2020;24:686-693.
PubMed Abstract available

RICKMAN HM, Cohn S, Lala SG, Waja Z, et al
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV.
Int J Tuberc Lung Dis. 2020;24:681-685.
PubMed Abstract available

MADHANI F, Maniar RA, Burfat A, Ahmed M, et al
Automated chest radiography and mass systematic screening for tuberculosis.
Int J Tuberc Lung Dis. 2020;24:665-673.
PubMed Abstract available

BASHAM CA, Grewal N, Orr PH, McMullin K, et al
What will it take to achieve meaningful action on tuberculosis among Indigenous Peoples?
Int J Tuberc Lung Dis. 2020;24:661-664.
PubMed

ROSSATO SILVA D, van den Hof S
Use of insurance claims and electronic health records to assess tuberculosis and latent tuberculosis diagnosis.
Int J Tuberc Lung Dis. 2020;24:659-660.
PubMed

TADYANEMHANDU C, Chirenda J, Garvey C, Metcalfe J, et al
Treatment success, but living with the consequences of post-tuberculosis sequelae.
Int J Tuberc Lung Dis. 2020;24:657-658.
PubMed

SCHAAF HS, du Preez K, Kruger M, Solomons R, et al
Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
Int J Tuberc Lung Dis. 2020;24:732-734.
PubMed

June 2020

DE SOUZA JVP, Murase LS, Caleffi-Ferracioli KR, Palomo CT, et al
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis.
Int J Tuberc Lung Dis. 2020;24:591-596.
PubMed Abstract available

GUPTA A, Singla R, Caminero JA, Singla N, et al
Impact of COVID-19 on tuberculosis services in India.
Int J Tuberc Lung Dis. 2020;24:637-639.
PubMed

SANDY C, Takarinda KC, Timire C, Mutunzi H, et al
Preparing national tuberculosis control programmes for COVID-19.
Int J Tuberc Lung Dis. 2020;24:634-636.
PubMed

PROOPS DC, Knorr JA, Meissner JS, Kreiswirth BN, et al
Epidemiology of tuberculosis among healthcare personnel in New York City.
Int J Tuberc Lung Dis. 2020;24:619-625.
PubMed Abstract available

COCOZZA AM, Linh NN, Jaramillo E
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?
Int J Tuberc Lung Dis. 2020;24:626-630.
PubMed Abstract available

ONGOLE JJ, Rossouw TM, Fourie PB, Stoltz AC, et al
Sustaining essential healthcare in Africa during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2020;24:643-645.
PubMed

VAN CREVEL R, Andia-Biraro I, Ntinginya NE, Chamba N, et al
Response to IJTLD article, "Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis".
Int J Tuberc Lung Dis. 2020;24:632-633.
PubMed

NAMKOONG H, Horita N, Ebina-Shibuya R
Concern over a COVID-19-related BCG shortage.
Int J Tuberc Lung Dis. 2020;24:642-643.
PubMed

MORAN A, Kula N, Jagwer G, Broughton E, et al
Examining the cost of community-based tuberculosis treatment in South Africa.
Int J Tuberc Lung Dis. 2020;24:612-618.
PubMed Abstract available

LAZARUS JV
Correspondence on: "Should we consider a 'fourth 90' for tuberculosis?"
Int J Tuberc Lung Dis. 2020;24:631-632.
PubMed

HARRIES AD
In Response to Reinout van Crevel et al.
Int J Tuberc Lung Dis. 2020;24:634.
PubMed

May 2020

PANG Y, Liu Y, Du J, Gao J, et al
Impact of COVID-19 on tuberculosis control in China.
Int J Tuberc Lung Dis. 2020;24:545-547.
PubMed

DARA M, Sotgiu G, Reichler MR, Chiang CY, et al
New diseases and old threats: lessons from tuberculosis for the COVID-19 response.
Int J Tuberc Lung Dis. 2020;24:544-545.
PubMed

PONTALI E, Tiberi S
Green Light Committee and drug-resistant-tuberculosis: how to address the new challenges?
Int J Tuberc Lung Dis. 2020;24:539.
PubMed

HENG M, Allmendinger S, Chiang CY, Trebucq A, et al
Progress in the roll-out of multidrug-resistant tuberculosis (MDR-TB) treatments.
Int J Tuberc Lung Dis. 2020;24:535-536.
PubMed

MONDONI M, Sotgiu G
Endobronchial ultrasound-guided transbronchial needle aspiration and tuberculosis mediastinal lymphadenopathy.
Int J Tuberc Lung Dis. 2020;24:534.
PubMed

ARINAMINPATHY N, Chin DP, Sachdeva KS, Rao R, et al
Modelling the potential impact of adherence technologies on tuberculosis in India.
Int J Tuberc Lung Dis. 2020;24:526-533.
PubMed Abstract available

GARFEIN RS, Liu L, Cuevas-Mota J, Collins K, et al
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment.
Int J Tuberc Lung Dis. 2020;24:520-525.
PubMed Abstract available

KAWATSU L, Uchimura K, Ohkado A
A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
Int J Tuberc Lung Dis. 2020;24:506-511.
PubMed Abstract available

MAUG AKJ, Hossain MA, Gumusboga M, Decroo T, et al
First-line tuberculosis treatment with double-dose rifampicin is well tolerated.
Int J Tuberc Lung Dis. 2020;24:499-505.
PubMed Abstract available

PARK SC, Kang MJ, Han CH, Lee SM, et al
Long-term mortality of patients with tuberculosis in Korea.
Int J Tuberc Lung Dis. 2020;24:492-498.
PubMed Abstract available

BUTOV D, Lange C, Heyckendorf J, Kalmykova I, et al
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.
Int J Tuberc Lung Dis. 2020;24:485-491.
PubMed Abstract available

ANDREWS JR, Cobelens F, Horsburgh CR, Hatherill M, et al
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town.
Int J Tuberc Lung Dis. 2020;24:477-484.
PubMed Abstract available

DENHOLM J
Seasonality, climate change and tuberculosis: new data and old lessons.
Int J Tuberc Lung Dis. 2020;24:469.
PubMed

COX V, Wilkinson L, Grimsrud A, Hughes J, et al
Critical changes to services for TB patients during the COVID-19 pandemic.
Int J Tuberc Lung Dis. 2020;24:542-544.
PubMed

ELGER BS, Mirzayev F, Afandiyev S, Gurbanova E, et al
Ethical issues in tuberculosis screening and the use of new drugs for prisoners.
Int J Tuberc Lung Dis. 2020;24:57-60.
PubMed Abstract available

HERMANNS S, Bhan A, Viney K
Ethics and benefits of systematic screening for active tuberculosis.
Int J Tuberc Lung Dis. 2020;24:44-47.
PubMed Abstract available

HUMMEL P, Ahamed N, Amanullah F
Ethical issues surrounding childhood tuberculosis.
Int J Tuberc Lung Dis. 2020;24:27-31.
PubMed Abstract available

DENHOLM JT, Millan-Marcelo JC, Fiekert K
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives.
Int J Tuberc Lung Dis. 2020;24:21-26.
PubMed Abstract available

BAYER R, Fairchild AL, Zignol M, Castro KG, et al
Tuberculosis surveillance and its discontents: the ethical paradox.
Int J Tuberc Lung Dis. 2020;24:9-14.
PubMed Abstract available

HARDING R, Snyman L, Ostgathe C, Odell S, et al
The ethical imperative to relieve suffering for people with tuberculosis by ensuring access to palliative care.
Int J Tuberc Lung Dis. 2020;24:3-8.
PubMed Abstract available

FURIN J
Can Green Light Committees help "end TB"?
Int J Tuberc Lung Dis. 2020;24:540.
PubMed

April 2020

KAPUR A
Randomised clinical trials for tuberculosis prophylaxis in people with diabetes mellitus.
Int J Tuberc Lung Dis. 2020;24:465-466.
PubMed

SHEDRAWY J, Jansson L, Bruchfeld J, Lonnroth K, et al
Health-related quality of life among persons treated for tuberculosis in a European setting.
Int J Tuberc Lung Dis. 2020;24:461-463.
PubMed

SCHWOEBEL V, Koura KG, Adjobimey M, Gnanou S, et al
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa.
Int J Tuberc Lung Dis. 2020;24:452-460.
PubMed Abstract available

YOUNG C, Barker S, Ehrlich R, Kistnasamy B, et al
Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa.
Int J Tuberc Lung Dis. 2020;24:444-451.
PubMed Abstract available

MIKIASHVILI L, Kipiani M, Schechter MC, Avaliani Z, et al
Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study.
Int J Tuberc Lung Dis. 2020;24:436-443.
PubMed Abstract available

PIERRE-AUDIGIER C, Talla C, Alame-Emane AK, Audigier B, et al
Tuberculosis trends in a hot-spot region in Paris, France.
Int J Tuberc Lung Dis. 2020;24:428-435.
PubMed Abstract available

TOMENY EM, Mendoza VL, Marcelo DB, Barrameda AJD, et al
Patient-cost survey for tuberculosis in the context of patient-pathway modelling.
Int J Tuberc Lung Dis. 2020;24:420-427.
PubMed Abstract available

O'SON L, Hulland E, Cookson ST, Castro KG, et al
Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon.
Int J Tuberc Lung Dis. 2020;24:414-419.
PubMed Abstract available

GOBAUD AN, Haley CA, Wilson JW, Bhavaraju R, et al
Multidrug-resistant tuberculosis care in the United States.
Int J Tuberc Lung Dis. 2020;24:409-413.
PubMed Abstract available

MCCREESH N, Grant AD, Yates TA, Karat AS, et al
Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest.
Int J Tuberc Lung Dis. 2020;24:403-408.
PubMed Abstract available

KIM HY, Hanrahan CF, Dowdy DW, Martinson NA, et al
Priorities among HIV-positive individuals for tuberculosis preventive therapies.
Int J Tuberc Lung Dis. 2020;24:396-402.
PubMed Abstract available

MASUKU SD, Berhanu R, Van Rensburg C, Ndjeka N, et al
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
Int J Tuberc Lung Dis. 2020;24:376-382.
PubMed Abstract available

MILLER CR, Mitchell EMH, Nishikiori N, Zwerling A, et al
ScreenTB: a tool for prioritising risk groups and selecting algorithms for screening for active tuberculosis.
Int J Tuberc Lung Dis. 2020;24:367-375.
PubMed Abstract available

LANEY AS, Pontali E
Computer-assisted interpretation of chest radiographs: signs of hope for silicosis and tuberculosis.
Int J Tuberc Lung Dis. 2020;24:362-363.
PubMed

CRUZ AT, Schwartzman K, Kitai I
Fighting a hidden epidemic: expanding tuberculosis preventive treatment to the youngest household contacts.
Int J Tuberc Lung Dis. 2020;24:357-359.
PubMed

BASHAM CA, Romanowski K, Johnston JC
Cardiovascular disease: the forgotten cousin of post-TB health?
Int J Tuberc Lung Dis. 2020;24:466-467.
PubMed

March 2020

HASKER E, Assoumani Y, Mzembaba A, Zakir AM, et al
Using a geographic information system as a management tool for tuberculosis control.
Int J Tuberc Lung Dis. 2020;24:354-356.
PubMed

YATES TA, Tomlinson LA, Douglas IJ
Proton pump inhibitors and tuberculosis risk.
Int J Tuberc Lung Dis. 2020;24:353-354.
PubMed

KOHLENBERG A, Kodmon C, van den Boom M, van der Werf MJ, et al
Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?
Int J Tuberc Lung Dis. 2020;24:347-352.
PubMed Abstract available

GUNASEKERA K, Cohen T, Gao W, Ayles H, et al
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey.
Int J Tuberc Lung Dis. 2020;24:340-346.
PubMed Abstract available

NGABONZIZA JS, Habimana YM, Decroo T, Migambi P, et al
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
Int J Tuberc Lung Dis. 2020;24:329-339.
PubMed Abstract available

BONSU F, Addo KK, Alebachew Z, Gyapong J, et al
National population-based tuberculosis prevalence survey in Ghana, 2013.
Int J Tuberc Lung Dis. 2020;24:321-328.
PubMed Abstract available

JANSSON L, Shedrawy J, Lonnroth K, Bruchfeld J, et al
Latent tuberculosis in pregnant women: a patient perspective.
Int J Tuberc Lung Dis. 2020;24:310-315.
PubMed Abstract available

LOPEZ-MEDINA EM, Sainz T, de Ory SJ, Mellado-Pena MJ, et al
Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study).
Int J Tuberc Lung Dis. 2020;24:303-309.
PubMed Abstract available

WANG M, Liu F, Li Q, Yin Q, et al
Quality assessment of guidelines for the management of Mycobacterium tuberculosis infection in children.
Int J Tuberc Lung Dis. 2020;24:287-294.
PubMed Abstract available

ARNEDO-PENA A, Juan-Cerdan JV, Romeu-Garcia M, Sorribes-Segura S, et al
Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain.
Int J Tuberc Lung Dis. 2020;24:278-286.
PubMed Abstract available

REICHLER MR, Hirsch-Moverman Y
Antenatal diagnosis of latent tuberculosis infection and post-partum treatment: patient perspectives.
Int J Tuberc Lung Dis. 2020;24:266-267.
PubMed

DEDICOAT M
Where next with for vitamin D and tuberculosis?
Int J Tuberc Lung Dis. 2020;24:265.
PubMed

DOWDY DW
The urgent need to improve clinical practice guidelines for pediatric tuberculosis.
Int J Tuberc Lung Dis. 2020;24:264.
PubMed

February 2020

SINGH AR, Shewade HD, Pandey R
Near real-time supervision of home visits for patients with tuberculosis.
Int J Tuberc Lung Dis. 2020;24:260-261.
PubMed

TALBOT EA
Response to Dr Granich's letter regarding 'Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations'.
Int J Tuberc Lung Dis. 2020;24:259.
PubMed

PARWATI CG, Farid MN, Nasution HS, Basri C, et al
Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia.
Int J Tuberc Lung Dis. 2020;24:250-257.
PubMed Abstract available

PARK S, Jo KW, Shim TS
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility.
Int J Tuberc Lung Dis. 2020;24:233-239.
PubMed Abstract available

QUISPE N, Asencios L, Obregon C, Velasquez GE, et al
The fourth national anti-tuberculosis drug resistance survey in Peru.
Int J Tuberc Lung Dis. 2020;24:207-213.
PubMed Abstract available

GATTI A, Ceriani C, De Paschale M, Magnani C, et al
Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis.
Int J Tuberc Lung Dis. 2020;24:196-201.
PubMed Abstract available

WANG EY, Arrazola RA, Mathema B, Ahluwalia IB, et al
The impact of smoking on tuberculosis treatment outcomes: a meta-analysis.
Int J Tuberc Lung Dis. 2020;24:170-175.
PubMed Abstract available

RABKIN M, Howard AA, Ehrenkranz P, Fernandez LG, et al
Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action.
Int J Tuberc Lung Dis. 2020;24:165-169.
PubMed Abstract available

GRANICH R
Time for hand wringing about TB diagnostics is over: show us the money and the impact.
Int J Tuberc Lung Dis. 2020;24:258-259.
PubMed

January 2020

WU MY, Shu CC, Lin HH
Authors reply to letter to the Editor "Chronic kidney disease, tuberculosis and climate change".
Int J Tuberc Lung Dis. 2020;24:133-134.
PubMed

HARRIES AD
Chronic kidney disease, tuberculosis and climate change.
Int J Tuberc Lung Dis. 2020;24:132-133.
PubMed

LEROLLE N, Laanani M, Galicier L, Riviere S, et al
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study.
Int J Tuberc Lung Dis. 2020;24:124-130.
PubMed Abstract available

LINH NN, Wares F, Cocozza AM, Uplekar M, et al
No universal access to drug-resistant tuberculosis care without engaging all health care providers.
Int J Tuberc Lung Dis. 2020;24:118-123.
PubMed Abstract available

DESHMUKH S, Atre S, Chavan A, Raskar S, et al
Assessment of the Xpert assay among adult pulmonary tuberculosis suspects with and without diabetes mellitus.
Int J Tuberc Lung Dis. 2020;24:113-117.
PubMed Abstract available

BARSS L, Moayedi-Nia S, Campbell JR, Oxlade O, et al
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2020;24:100-109.
PubMed Abstract available

CHEN MP, Miramontes R, Kammerer JS
Multidrug-resistant tuberculosis in the United States, 2011-2016: patient characteristics and risk factors.
Int J Tuberc Lung Dis. 2020;24:92-99.
PubMed Abstract available

HILL J, Dickson-Hall L, Grant AD, Grundy C, et al
Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data.
Int J Tuberc Lung Dis. 2020;24:83-91.
PubMed Abstract available

RAGAN EJ, Kleinman MB, Sweigart B, Gnatienko N, et al
The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2020;24:73-82.
PubMed Abstract available

HONG H, Dowdy DW, Dooley KE, Francis HW, et al
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
Int J Tuberc Lung Dis. 2020;24:65-72.
PubMed Abstract available

PERUMAL R, Naidoo K, Naidoo A, Ramachandran G, et al
A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes.
Int J Tuberc Lung Dis. 2020;24:48-64.
PubMed Abstract available

COCOZZA AM, Linh NN, Nathavitharana RR, Ahmad U, et al
An assessment of current tuberculosis patient care and support policies in high-burden countries.
Int J Tuberc Lung Dis. 2020;24:36-42.
PubMed Abstract available

REEVES H, Grandjean Lapierre S, Razafindrina K, Andriamiadanarivo A, et al
Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar.
Int J Tuberc Lung Dis. 2020;24:28-35.
PubMed Abstract available

GUTIERREZ C, Somoskovi A
Serum levels of tuberculosis drugs-beyond the quantitative data.
Int J Tuberc Lung Dis. 2020;24:6-7.
PubMed

CHAULK CP, Moonan PK
Over the limit: tuberculosis and excessive alcohol use.
Int J Tuberc Lung Dis. 2020;24:3-4.
PubMed

December 2019

DENHOLM JT, Leontiou C, McKeown A, Watts KN, et al
Speaking up: language services, tuberculosis and human rights.
Int J Tuberc Lung Dis. 2019;23:1336.
PubMed

MEKONNEN D, Derbie A, Abeje A, Shumet A, et al
Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2019;23:1314-1326.
PubMed Abstract available

SURIE D, Interrante JD, Pathmanathan I, Patel MR, et al
Policies, practices and barriers to implementing tuberculosis preventive treatment-35 countries, 2017.
Int J Tuberc Lung Dis. 2019;23:1308-1313.
PubMed Abstract available

LIFAN Z, Sainan B, Feng S, Siyan Z, et al
Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2019;23:1293-1307.
PubMed Abstract available

HANDEL A, Martinez L, Sekandi JN, Bellan SE, et al
Evidence for supercoughers in an analysis of six tuberculosis cohorts from China, Peru, The Gambia and Uganda.
Int J Tuberc Lung Dis. 2019;23:1286-1292.
PubMed Abstract available

ZMAK L, Obrovac M, Makek MJ, Perko G, et al
From Peruvian mummies to living humans: first case of pulmonary tuberculosis caused by Mycobacterium pinnipedii.
Int J Tuberc Lung Dis. 2019;23:1283-1285.
PubMed Abstract available

SOH AZ, Chee CBE, Wang YT, Yuan JM, et al
Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort.
Int J Tuberc Lung Dis. 2019;23:1277-1282.
PubMed Abstract available

PENG Y, Zhu Y, Ao G, Chen Z, et al
Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis.
Int J Tuberc Lung Dis. 2019;23:1269-1276.
PubMed Abstract available

WADEMAN DT, Busakwe L, Nicholson TJ, van der Zalm M, et al
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.
Int J Tuberc Lung Dis. 2019;23:1263-1268.
PubMed Abstract available

CHANDAK RJ, Malhotra B, Bhargava S, Goel SK, et al
Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs.
Int J Tuberc Lung Dis. 2019;23:1257-1262.
PubMed Abstract available

DUNSTAN SJ, Williamson DA, Denholm JT
Understanding the global tuberculosis epidemic: moving towards routine whole-genome sequencing.
Int J Tuberc Lung Dis. 2019;23:1241-1242.
PubMed

HARRIES AD
Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis.
Int J Tuberc Lung Dis. 2019;23:1237-1238.
PubMed

SUDBURY E, Villanueva P, Goetzinger F, Tebruegge M, et al
The impact of bacille Calmette-Guerin vaccination on tuberculin skin test results in young children.
Int J Tuberc Lung Dis. 2019;23:1335-1336.
PubMed

November 2019

HARRIES AD, Dlodlo RA, Brigden G, Mortimer K, et al
Should we consider a 'fourth 90' for tuberculosis?
Int J Tuberc Lung Dis. 2019 Nov 21. doi: 10.5588/ijtld.19.0471.
PubMed Abstract available

TIMIRE C, Sandy C, Harries AD
Eliminating tuberculosis by 2035: tackling the financial barriers at all stages of the cascade of care.
Int J Tuberc Lung Dis. 2019;23:1235.
PubMed

COIT J, Mendoza M, Pinedo C, Marin H, et al
Performance of a household tuberculosis exposure survey among children in a Latin American setting.
Int J Tuberc Lung Dis. 2019;23:1223-1227.
PubMed Abstract available

RIVERA VR, Lu L, Ocheretina O, Jean Juste MA, et al
Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti.
Int J Tuberc Lung Dis. 2019;23:1217-1222.
PubMed Abstract available

SUMALANI KK, Akhter N, Chawla D, Rizvi NA, et al
Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi.
Int J Tuberc Lung Dis. 2019;23:1213-1216.
PubMed Abstract available

ERLINGER S, Stracker N, Hanrahan C, Nonyane S, et al
Tuberculosis patients with higher levels of poverty face equal or greater costs of illness.
Int J Tuberc Lung Dis. 2019;23:1205-1212.
PubMed Abstract available

JORDAN AM, Podewils LJ, Castro KG, Zishiri V, et al
Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015.
Int J Tuberc Lung Dis. 2019;23:1198-1204.
PubMed Abstract available

VINEY K, Amaral S, Marques EB, Siroka A, et al
Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste.
Int J Tuberc Lung Dis. 2019;23:1191-1197.
PubMed Abstract available

AUGUSTE P, Madan J, Tsertsvadze A, Court R, et al
Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy.
Int J Tuberc Lung Dis. 2019;23:1178-1190.
PubMed Abstract available

CADMUS S, Akinseye VO, van Soolingen D
Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975-2014.
Int J Tuberc Lung Dis. 2019;23:1162-1170.
PubMed Abstract available

SCHULMAN H, Niward K, Abate E, Idh J, et al
Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis.
Int J Tuberc Lung Dis. 2019;23:1155-1161.
PubMed Abstract available

LAM CK, Fluegge K, Macaraig M, Burzynski J, et al
Cost savings associated with video directly observed therapy for treatment of tuberculosis.
Int J Tuberc Lung Dis. 2019;23:1149-1154.
PubMed Abstract available

BOCCIA D, Bond V
The catastrophic cost of tuberculosis: advancing research and solutions.
Int J Tuberc Lung Dis. 2019;23:1129-1130.
PubMed

SCHON T
The evaluation of routine immunological tests to estimate the risk of progression into active tuberculosis.
Int J Tuberc Lung Dis. 2019;23:1127-1128.
PubMed

PEDRAZZOLI D, Houben R, Viney K, Lonnroth K, et al
Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB.
Int J Tuberc Lung Dis. 2019;23:1236.
PubMed

October 2019

FIOGBE AA, Agodokpessi G, Marcy O
In reply to: Programmatic implementation of screening and management of pulmonary impairment post-tuberculosis in resource-limited countries: challenges and feasibility.
Int J Tuberc Lung Dis. 2019;23:1123.
PubMed

OLIVEIRA MCB, Sant'Anna CC, Luiz RR, Soares ECC, et al
Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil.
Int J Tuberc Lung Dis. 2019;23:1115-1121.
PubMed Abstract available

CAMELIQUE O, Scholtissen S, Dousset JP, Bonnet M, et al
Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia.
Int J Tuberc Lung Dis. 2019;23:1107-1114.
PubMed Abstract available

VALVI C, Chandanwale A, Khadse S, Kulkarni R, et al
Delays and barriers to early treatment initiation for childhood tuberculosis in India.
Int J Tuberc Lung Dis. 2019;23:1090-1099.
PubMed Abstract available

BHERING M, Kritski A, Nunes C, Duarte R, et al
Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014.
Int J Tuberc Lung Dis. 2019;23:1075-1081.
PubMed Abstract available

COURT R, Chirehwa MT, Wiesner L, de Vries N, et al
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis.
Int J Tuberc Lung Dis. 2019;23:1068-1074.
PubMed Abstract available

BASTARD M, Sanchez-Padilla E, Hayrapetyan A, Kimenye K, et al
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?
Int J Tuberc Lung Dis. 2019;23:1060-1067.
PubMed Abstract available

VINEY K, Mills T, Harley D
Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c.
Int J Tuberc Lung Dis. 2019;23:1055-1059.
PubMed Abstract available

GUGLIELMETTI L, Jaffre J, Bernard C, Brossier F, et al
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
Int J Tuberc Lung Dis. 2019;23:1050-1054.
PubMed Abstract available

PONTALI E, Tadolini M, Migliori GB
TB consilia and quality of tuberculosis management.
Int J Tuberc Lung Dis. 2019;23:1048-1049.
PubMed

DOWDY DW
Implementation of Xpert((R)) MTB/RIF: real challenges, real promise.
Int J Tuberc Lung Dis. 2019;23:1123.
PubMed

TADYANEMHANDU C, Garvey C, Chin A, Metcalfe J, et al
More should be done now for patients with TB-associated chronic lung disease.
Int J Tuberc Lung Dis. 2019;23:1122-1123.
PubMed

JINDAL SK
Searching for a mole in the hill.
Int J Tuberc Lung Dis. 2019;23:1047.
PubMed

September 2019

VANINO E, Tadolini M, Attard L, Cascavilla A, et al
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.
Int J Tuberc Lung Dis. 2019;23:1042.
PubMed

GALEGO MA, Santos JV, Viana J, Freitas A, et al
To be or not to be hospitalised with tuberculosis in Portugal.
Int J Tuberc Lung Dis. 2019;23:1029-1034.
PubMed Abstract available

DI BELLA S, Siroka A, Antonello RM, Zignol M, et al
Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
Int J Tuberc Lung Dis. 2019;23:1024-1028.
PubMed Abstract available

HUGHES J, Reuter A, Chabalala B, Isaakidis P, et al
Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.
Int J Tuberc Lung Dis. 2019;23:1017-1023.
PubMed Abstract available

PEREA-JACOBO R, Muniz-Salazar R, Laniado-Laborin R, Cabello-Pasini A, et al
Rifampin pharmacokinetics in tuberculosis-diabetes mellitus patients: a pilot study from Baja California, Mexico.
Int J Tuberc Lung Dis. 2019;23:1012-1016.
PubMed Abstract available

BUZIASHVILI M, Mirtskhulava V, Kipiani M, Blumberg HM, et al
Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.
Int J Tuberc Lung Dis. 2019;23:1005-1011.
PubMed Abstract available

OTA M, Uchimura K
Trends of tuberculosis rates before and after the declaration as a public health emergency in Japan, 1992-2006.
Int J Tuberc Lung Dis. 2019;23:1000-1004.
PubMed Abstract available

HELD K, McAnaw S, Chiang CY, Trebucq A, et al
Progress in global rollout of new multidrug-resistant tuberculosis treatments.
Int J Tuberc Lung Dis. 2019;23:996-999.
PubMed Abstract available

ZHANG HC, Ruan QL, Wu J, Zhang S, et al
Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China.
Int J Tuberc Lung Dis. 2019;23:989-995.
PubMed Abstract available

FARLEY JE, McKenzie-White J, Bollinger R, Hong H, et al
Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis.
Int J Tuberc Lung Dis. 2019;23:980-988.
PubMed Abstract available

SMITTIPAT N, Miyahara R, Juthayothin T, Billamas P, et al
Indo-Oceanic Mycobacterium tuberculosis strains from Thailand associated with higher mortality.
Int J Tuberc Lung Dis. 2019;23:972-979.
PubMed Abstract available

MISHRA B, Mohapatra PR
Expand the RRDR hotspot to improve GeneXpert results.
Int J Tuberc Lung Dis. 2019;23:1043.
PubMed

HARRIES AD, Chakaya JM
Assessing and managing pulmonary impairment in those who have completed TB treatment in programmatic settings.
Int J Tuberc Lung Dis. 2019;23:1044-1045.
PubMed

HARRIES AD, Timire C, Takarinda KC, Sandy C, et al
Ensuring that Xpert((R)) MTB/RIF is used to its maximum potential.
Int J Tuberc Lung Dis. 2019;23:1043-1044.
PubMed

July 2019

MARTINEZ-GIRON R, van Woerden HC
The recognition of Lophomonas blattarum in fresh respiratory samples in recent correspondence.
Int J Tuberc Lung Dis. 2019;23:873-874.
PubMed

SILVA A, Ponte C, Antas PRZ
What a difference a strain makes!
Int J Tuberc Lung Dis. 2019;23:874.
PubMed

NDAKIDEMI E, Emerson C, Medley A, Ngowi B, et al
Health care worker perspectives on TB case finding and HIV services among pediatric TB patients in Tanzania.
Int J Tuberc Lung Dis. 2019;23:811-816.
PubMed Abstract available

June 2019

KAMAT AS, Gretschel A, Vlok AJ, Solomons R, et al
Reply to "Cerebrospinal fluid protein and shunt obstruction in tuberculous meningitis".
Int J Tuberc Lung Dis. 2019;23:767-768.
PubMed

FIGAJI A, Fieggen G, Enslin N, Taylor A, et al
Cerebrospinal fluid protein and shunt obstruction in tuberculous meningitis.
Int J Tuberc Lung Dis. 2019;23:765.
PubMed

ASSEFA Y, Woldeyohannes S, Gelaw YA, Hamada Y, et al
Screening tools to exclude active pulmonary TB in high TB burden countries: systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2019;23:728-734.
PubMed Abstract available

May 2019

MITCHELL EMH, Heumann SG, Sprague L, Tesfaye DH, et al
'Reservoir of infection' or 'fount of knowledge'? Forging equal partnerships and shifting power to address LTBI.
Int J Tuberc Lung Dis. 2019;23:527-528.
PubMed

HAROUNA SH, Ortuno-Gutierrez N, Souleymane MB, Kizito W, et al
Short-course treatment outcomes and adverse events in adults and children-adolescents with MDR-TB in Niger.
Int J Tuberc Lung Dis. 2019;23:625-630.
PubMed Abstract available

ISMAIL NA, Said HM, Rodrigues C, Omar SV, et al
Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing.
Int J Tuberc Lung Dis. 2019;23:594-599.
PubMed Abstract available

BERROCAL-ALMANZA LC, Botticello J, Piotrowski H, Karnani N, et al
Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.
Int J Tuberc Lung Dis. 2019;23:563-570.
PubMed Abstract available

April 2019

KYI MS, Aung ST, Oo HN, Chongsuvivatwong V, et al
Fully vs. partially integrated services for TB-HIV in Myanmar: a health services review and a cohort study.
Int J Tuberc Lung Dis. 2019;23:498-506.
PubMed Abstract available

EPSTEIN RL, Bhagavathula M, Saag LA, Verma S, et al
QuantiFERON((R))-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA.
Int J Tuberc Lung Dis. 2019;23:482-490.
PubMed Abstract available

March 2019

BERHANU RH, Schnippel K, Kularatne R, Firnhaber C, et al
Discordant rifampicin susceptibility results are associated with Xpert((R)) MTB/RIF probe B and probe binding delay.
Int J Tuberc Lung Dis. 2019;23:358-362.
PubMed Abstract available

LAI J, Dememew Z, Jerene D, Abashawl A, et al
Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia.
Int J Tuberc Lung Dis. 2019;23:371-377.
PubMed Abstract available

KURTZ T, Feil AC, Nascimento LS, de Oliveira Abreu P, et al
Effect of neonatal bacille Calmette-Guerin on the tuberculin skin test reaction in the first 2 years of life.
Int J Tuberc Lung Dis. 2019;23:344-348.
PubMed Abstract available

KYAW NTT, Kumar AMV, Kyaw KWY, Satyanarayana S, et al
IPT in people living with HIV in Myanmar: a five-fold decrease in incidence of TB disease and all-cause mortality.
Int J Tuberc Lung Dis. 2019;23:322-330.
PubMed Abstract available

February 2019

SULEIMAN K, England K, Lessem E, McKenna L, et al
Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspective.
Int J Tuberc Lung Dis. 2019;23:272.
PubMed

SYKES CA, Shepherd J, McGoldrick C, Kennedy N, et al
A case of rifampicin-induced haemolysis.
Int J Tuberc Lung Dis. 2019;23:239-240.
PubMed Abstract available

VAN AERDE KJ, van der Heijden EHFM, Henriet SS, Merkus PJ, et al
A case promoting use of ultrasound-guided sampling techniques to correctly diagnose MDR-TB in children.
Int J Tuberc Lung Dis. 2019;23:236-238.
PubMed Abstract available

RENDON A, Silva DR, Esposito S, Sotgiu G, et al
Launching the Global TB Network.
Int J Tuberc Lung Dis. 2019;23:123-124.
PubMed

January 2019

REIMANN M, Schaub D, Kalsdorf B, Runge C, et al
Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
Int J Tuberc Lung Dis. 2019;23:93-98.
PubMed Abstract available

AGIZEW T, Boyd R, Auld AF, Payton L, et al
Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
Int J Tuberc Lung Dis. 2019;23:82-92.
PubMed Abstract available

PEDRAZZOLI D, Borghi J, Viney K, Houben RMGJ, et al
Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
Int J Tuberc Lung Dis. 2019;23:5-11.
PubMed Abstract available

AGGERBECK H, Ruhwald M, Hoff ST, Tingskov PN, et al
Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.
Int J Tuberc Lung Dis. 2019;23:38-44.
PubMed Abstract available

VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
Sputum smear microscopy in the Xpert((R)) MTB/RIF era.
Int J Tuberc Lung Dis. 2019;23:12-18.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: